TRDA
Entrada Therapeutics, Inc. · Healthcare
President and CEO Dipal Doshi sold $27K of Entrada Therapeutics, Inc.
Sold$27,422
$13.71Price
2,000Shares
−1%Stake
What TRDA did after the filing
- The stock from Mon, May 1 close, $12.76
- +27.0%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jun 13 close.
Traded Thu, Apr 27. Filed Mon, May 1, 12:38 PM ET, during the session. Returns use the May 1 close and the Jun 13 close. Not investment advice.